Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03011931 · ClinicalTrials.gov registry record · Early Phase 1
Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568]
A Early Phase 1 study of Celiac Disease, sponsored by Entero Therapeutics.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 40
- Enrollment target
- 1
- Study location
NCT03011931: Completed Early Phase 1 study of Celiac Disease, sponsored by Entero Therapeutics.
NCT03011931 is a Early Phase 1 study of Celiac Disease that has completed, run by Entero Therapeutics. The registered enrollment target is 40 participants, below the 1,978-participant average among 24 other Celiac Disease trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03011931, a Early Phase 1 study of Celiac Disease, has completed, sponsored by Entero Therapeutics.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 40 participants
- Enrollment target
- 1
- Study location
Study Summary
To study the correlation between simvastatin metabolism by the enterocyte and the histologic state of the intestine in treated celiac disease.
Conditions Studied
Interventions
- DRUG Simvastatin
Study Locations (1)
Minnesota
- Mayo Clinic in Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2016-03 |
| Est. Completion | 2019-02 |
| Phase | Early Phase 1 |
What the finished NCT03011931 record still lists
NCT03011931 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,978-participant average among 24 other Celiac Disease trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Celiac Disease appearing as the primary indexed condition, and to 1 intervention - of which Simvastatin is the first listed.
NCT03011931 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT03011931 about?
NCT03011931 is a clinical study titled "Simvastatin Metabolism as a Test for CD Activity (IRB 15-007568]". To study the correlation between simvastatin metabolism by the enterocyte and the histologic state of the intestine in treated celiac disease.
What is the current status of trial NCT03011931?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 40 participants. The study started on 2016-03. Estimated completion is 2019-02.
What conditions does trial NCT03011931 study?
This clinical trial studies the following conditions: Celiac Disease.
What interventions are being tested in trial NCT03011931?
The interventions under investigation include: Simvastatin (DRUG).
Who is sponsoring clinical trial NCT03011931?
This trial is sponsored by Entero Therapeutics, which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03011931 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Celiac Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03011931's enrollment target sits among peer trials
40 19th of 24 higher than 4 of 24 other Celiac Disease trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Celiac Disease trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
VTP-1000 in Adults With Celiac Disease
RECRUITING · Early Phase 1
-
Tissue Destruction and Healing in Celiac Disease
RECRUITING · NA
-
Celiac Disease Genomic Environmental Microbiome and Metabolomic Study
RECRUITING
-
A First-in-human Study to Evaluate the Safety and Tolerability of HB-2121 as a Diagnostic for Celiac Disease
RECRUITING · Phase 1
-
Unhide® Project: A Digital Health Platform to Collect Lifestyle Data for Brain Inflammation Research
RECRUITING
-
Immune Responses to Gluten
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia